Brain or B type natriuretic peptide is increasingly used as a marker of congestive heart failure. It has high specificity for the condition. It is released by ventricular cardiomyocytes due to stretch as part of the pathophysiology of cardiac failure.

GIIB/IIIA inhibitors such as Reopro or Tirofibran have a treatment role in NSTEMI